TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.
Peter Schmid et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.